Hollow-Fiber Pharmacodynamic Studies and Mathematical Modeling To Predict the Efficacy of Amoxicillin for Anthrax Postexposure Prophylaxis in Pregnant Women and Children

Por Louie, Arnold, VanScoy, Brian, Liu, Weiguo, Kulawy, Robert, Drusano, G. L.
Publicado em 2013

Comparative Efficacies of Candidate Antibiotics against Yersinia pestis in an In Vitro Pharmacodynamic Model

Por Louie, Arnold, VanScoy, Brian, Liu, Weiguo, Kulawy, Robert, Brown, David, Heine, Henry S., Drusano, George L.
Publicado em 2011

Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model

Por VanScoy, Brian, McCauley, Jennifer, Bhavnani, Sujata M., Ellis-Grosse, Evelyn J., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2016)

The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression

Por Louie, Arnold, Grasso, Caroline, Bahniuk, Nadzeya, Van Scoy, Brian, Brown, David L., Kulawy, Robert, Drusano, G. L.
Publicado em 2010

Impact of Spores on the Comparative Efficacies of Five Antibiotics for Treatment of Bacillus anthracis in an In Vitro Hollow Fiber Pharmacodynamic Model

Por Louie, Arnold, VanScoy, Brian D., Brown, David L., Kulawy, Robert W., Heine, Henry S., Drusano, George L.
Publicado em 2012

Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself

Por Ambrose, Paul G., VanScoy, Brian, Conde, Haley, McCauley, Jennifer, Rubino, Christopher M., Bhavnani, Sujata M.
Publicado no Antimicrob Agents Chemother (2016)

Dose Range Evaluation of Mycograb C28Y Variant, a Human Recombinant Antibody Fragment to Heat Shock Protein 90, in Combination with Amphotericin B-Desoxycholate for Treatment of Mu...

Por Louie, Arnold, Stein, Daniel S., Zack, Julia Z., Liu, Weiguo, Conde, Haley, Fregeau, Christine, VanScoy, Brian D., Drusano, George L.
Publicado em 2011

Is 60 Days of Ciprofloxacin Administration Necessary for Postexposure Prophylaxis for Bacillus anthracis?

Por Drusano, G. L., Okusanya, Olanrewaju O., Okusanya, Adedoyin, Van Scoy, Brian, Brown, D. L., Kulawy, Robert, Sörgel, Fritz, Heine, Henry S., Louie, Arnold
Publicado em 2008

Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in an In Vitro Pharmacodynamic System

Por Louie, Arnold, VanScoy, Brian D., Heine, Henry S., Liu, Weiguo, Abshire, Terry, Holman, Kari, Kulawy, Robert, Brown, David L., Drusano, George L.
Publicado em 2012

Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model

Por VanScoy, Brian D., McCauley, Jennifer, Ellis-Grosse, Evelyn J., Okusanya, Olanrewaju O., Bhavnani, Sujata M., Forrest, Alan, Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2015)

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

Por VanScoy, Brian D., Trang, Michael, McCauley, Jennifer, Conde, Haley, Bhavnani, Sujata M., Friedrich, Lawrence V., Alexander, Dylan C., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2016)

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Por Louie, Arnold, Castanheira, Mariana, Liu, Weiguo, Grasso, Caroline, Jones, Ronald N., Williams, Gregory, Critchley, Ian, Thye, Dirk, Brown, David, VanScoy, Brian, Kulawy, Robert, Drusano, G. L.
Publicado em 2012

Relationship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model

Por VanScoy, Brian D., Mendes, Rodrigo E., Castanheira, Mariana, McCauley, Jennifer, Bhavnani, Sujata M., Jones, Ronald N., Friedrich, Lawrence V., Steenbergen, Judith N., Ambrose, Paul G.
Publicado em 2014

Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa

Por Drusano, G. L., Bonomo, Robert A., Bahniuk, Nadzeya, Bulitta, Juergen B., VanScoy, Brian, DeFiglio, Holland, Fikes, Steven, Brown, David, Drawz, Sarah M., Kulawy, Robert, Louie, Arnold
Publicado em 2012

The Use of Streptolysin O for the Treatment of Scars, Adhesions and Fibrosis: Initial Investigations Using Murine Models of Scleroderma

Por Mamber, Stephen W., Long, Vit, Rhodes, Ryan G., Pond-Tor, Sunthorn, Wheeler, Lyn R., Fredericks, Kellie, VanScoy, Brian, Sauniere, Jean-Frederic, Steinschneider, Remy, Laurent, Jean-Claude, McMichael, John
Publicado em 2004

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Por VanScoy, Brian, Mendes, Rodrigo E., Castanheira, Mariana, McCauley, Jennifer, Bhavnani, Sujata M., Forrest, Alan, Jones, Ronald N., Okusanya, Olanrewaju O., Friedrich, Lawrence V., Steenbergen, Judith, Ambrose, Paul G.
Publicado em 2013

Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance

Por Louie, Arnold, Bied, Adam, Fregeau, Christine, Van Scoy, Brian, Brown, David, Liu, Weiguo, Bush, Karen, Queenan, Anne-Marie, Morrow, Brian, Khashab, Mohammed, Kahn, James B., Nicholson, Susan, Kulawy, Robert, Drusano, G. L.
Publicado em 2010

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Por VanScoy, Brian, Mendes, Rodrigo E., McCauley, Jennifer, Bhavnani, Sujata M., Bulik, Catharine C., Okusanya, Olanrewaju O., Forrest, Alan, Jones, Ronald N., Friedrich, Lawrence V., Steenbergen, Judith N., Ambrose, Paul G.
Publicado em 2013

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Por VanScoy, Brian, Mendes, Rodrigo E., Nicasio, Anthony M., Castanheira, Mariana, Bulik, Catharine C., Okusanya, Olanrewaju O., Bhavnani, Sujata M., Forrest, Alan, Jones, Ronald N., Friedrich, Lawrence V., Steenbergen, Judith N., Ambrose, Paul G.
Publicado em 2013

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Por Nicasio, Anthony M., VanScoy, Brian D., Mendes, Rodrigo E., Castanheira, Mariana, Bulik, Catharine C., Okusanya, Olanrewaju O., Bhavnani, Sujata M., Forrest, Alan, Jones, Ronald N., Friedrich, Lawrence V., Steenbergen, Judith N., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2016)